Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.02
(0.86%)
CNY 7.02
(0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 853.66 Million | 830.04 Million | 877.92 Million | 842.58 Million | 1.01 Billion | 975.08 Million |
| Cost of Revenue | 224.2 Million | 216.52 Million | 220.53 Million | 214.7 Million | 249.51 Million | 222.83 Million |
| Gross Profit | 629.46 Million | 613.51 Million | 657.39 Million | 627.88 Million | 763.23 Million | 752.25 Million |
| Operating Expenses | 513.73 Million | 505.54 Million | 524.73 Million | 499.16 Million | 615.01 Million | 605.41 Million |
| Selling, General and Administrative Expenses | 489.13 Million | 422.78 Million | 447.08 Million | 438.88 Million | 543.22 Million | 550.9 Million |
| Research and Development Expenses | 16.51 Million | 18.77 Million | 20.89 Million | 15.71 Million | 19.47 Million | 19.52 Million |
| Other Expenses | 8.07 Million | 63.98 Million | 56.75 Million | 44.56 Million | 52.32 Million | -6.56 Million |
| Cost and Expenses | 737.93 Million | 722.07 Million | 745.27 Million | 713.86 Million | 864.52 Million | 828.24 Million |
| Operating Income | 115.73 Million | 102.66 Million | 128.63 Million | 109.74 Million | 110.99 Million | 106.69 Million |
| Interest Expense | 13.77 Million | 14.03 Million | 13.36 Million | 13.09 Million | 17.01 Million | 22.63 Million |
| Income Tax Expense | 15.65 Million | 12.9 Million | 18.67 Million | 15.42 Million | 15.78 Million | 15.21 Million |
| Earnings before Tax | 111.76 Million | 101.22 Million | 123.36 Million | 105.03 Million | 108.11 Million | 100.12 Million |
| Net Income | 94.73 Million | 83.09 Million | 96.02 Million | 80.06 Million | 76.59 Million | 69.07 Million |
| Earnings Per Share Basic | 0.29 | 0.25 | 0.29 | 0.24 | 0.23 | 0.21 |
| Earnings Per Share Diluted | 0.29 | 0.25 | 0.29 | 0.24 | 0.23 | 0.21 |
| Weighted Average Shares Outstanding | 330.95 Million | 330.95 Million | 330.95 Million | 330.95 Million | 330.95 Million | 330.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 330.95 Million | 330.95 Million | 330.95 Million | 330.95 Million | 330.95 Million | 330.99 Million |
| Gross Margin | 0.74 | 0.74 | 0.75 | 0.75 | 0.75 | 0.77 |
| EBIT Margin | 0.21 | 0.19 | 0.20 | 0.20 | 0.19 | 0.19 |
| Profit Margin | 0.11 | 0.10 | 0.11 | 0.10 | 0.08 | 0.07 |
| EBITDA | 175.99 Million | 160.53 Million | 179.81 Million | 159.53 Million | 167.56 Million | 163.68 Million |
| Earnings Before Tax Margin | 0.14 | 0.12 | 0.15 | 0.13 | 0.11 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 157.71 Million | 143.75 Million | 200.38 Million | 198.78 Million | 836.2 Million | 181.72 Million |
| Cost of Revenue | 46.37 Million | 39.32 Million | 46.38 Million | 51.09 Million | 246.34 Million | 46.4 Million |
| Gross Profit | 111.34 Million | 104.43 Million | 153.99 Million | 147.68 Million | 589.86 Million | 135.31 Million |
| Operating Expenses | 109.33 Million | 101.98 Million | 128.87 Million | 114.97 Million | 503.04 Million | 123.48 Million |
| Selling, General and Administrative Expenses | 162.46 Million | 97.81 Million | 123.78 Million | 113.3 Million | - | 152.82 Million |
| Research and Development Expenses | 4.82 Million | 4.16 Million | 5 Million | 2.66 Million | - | 4.79 Million |
| Other Expenses | -57.96 Million | -366.66 Thousand | -1.32 Million | 994.12 Thousand | 2.6 Million | 173.97 Thousand |
| Cost and Expenses | 155.7 Million | 141.3 Million | 175.26 Million | 166.07 Million | 749.38 Million | 169.88 Million |
| Operating Income | -328.25 Thousand | 2.44 Million | 26.32 Million | 32.71 Million | 86.81 Million | 12.33 Million |
| Interest Expense | 3.59 Million | 4.03 Million | 2.82 Million | 3.43 Million | 13.66 Million | 3.44 Million |
| Income Tax Expense | -542.05 Thousand | 1.93 Million | 3.58 Million | 5.69 Million | 15.65 Million | 2.27 Million |
| Earnings before Tax | -501.33 Thousand | 13.87 Million | 25 Million | 41.6 Million | 111.76 Million | 12.5 Million |
| Net Income | 2.52 Million | 12.31 Million | 21.01 Million | 36.26 Million | 94.73 Million | 11.04 Million |
| Earnings Per Share Basic | 0.01 | 0.04 | 0.06 | 0.11 | - | 0.03 |
| Earnings Per Share Diluted | 0.01 | 0.04 | 0.06 | 0.11 | - | 0.03 |
| Weighted Average Shares Outstanding | 330.95 Million | 330.95 Million | 330.96 Million | 330.95 Million | 330.95 Million | 330.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 330.95 Million | 330.95 Million | 330.96 Million | 330.95 Million | 330.95 Million | 330.95 Million |
| Gross Margin | 0.71 | 0.73 | 0.77 | 0.74 | 0.71 | 0.74 |
| EBIT Margin | 0.02 | 0.10 | 0.15 | 0.23 | - | 0.09 |
| Profit Margin | 0.02 | 0.09 | 0.10 | 0.18 | 0.11 | 0.06 |
| EBITDA | 3.09 Million | 14.05 Million | 29.51 Million | 45.31 Million | - | 15.69 Million |
| Earnings Before Tax Margin | -0.00 | 0.02 | 0.13 | 0.16 | 0.10 | 0.07 |
BSS
MSUMI
0I6Q
4306
AEROFLEX
WCN